Medexus Pharmaceuticals Stock Price Patterns
| MDP Stock | 2.81 0.03 1.06% |
Momentum 49
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.80) | EPS Estimate Next Quarter (0.02) | EPS Estimate Current Year (0.08) | EPS Estimate Next Year 0.369 | Wall Street Target Price 6.8875 |
Using Medexus Pharmaceuticals hype-based prediction, you can estimate the value of Medexus Pharmaceuticals from the perspective of Medexus Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Medexus Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Medexus because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Medexus Pharmaceuticals after-hype prediction price | CAD 2.81 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Medexus |
Medexus Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Medexus Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Medexus Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Medexus Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Medexus Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Medexus Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Medexus Pharmaceuticals' historical news coverage. Medexus Pharmaceuticals' after-hype downside and upside margins for the prediction period are 0.52 and 5.10, respectively. We have considered Medexus Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Medexus Pharmaceuticals is relatively risky at this time. Analysis and calculation of next after-hype price of Medexus Pharmaceuticals is based on 3 months time horizon.
Medexus Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Medexus Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medexus Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Medexus Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.09 | 2.29 | 0.00 | 0.00 | 3 Events / Month | 0 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.81 | 2.81 | 0.00 |
|
Medexus Pharmaceuticals Hype Timeline
Medexus Pharmaceuticals is now traded for 2.81on Toronto Exchange of Canada. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Medexus is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is now at 0.09%. %. The volatility of related hype on Medexus Pharmaceuticals is about 15266.67%, with the expected price after the next announcement by competition of 2.81. The company has price-to-book ratio of 1.3. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medexus Pharmaceuticals last dividend was issued on the 19th of December 2018. The entity had 1:15 split on the 19th of December 2018. Assuming the 90 days trading horizon the next projected press release will be in about 3 days. Check out Medexus Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Medexus Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Medexus Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Medexus Pharmaceuticals' future price movements. Getting to know how Medexus Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Medexus Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DB | Decibel Cannabis | 0.01 | 3 per month | 0.00 | (0.06) | 10.00 | (9.09) | 20.00 | |
| CRDL | Cardiol Therapeutics Class | 0.02 | 7 per month | 3.54 | 0 | 6.11 | (4.76) | 20.37 |
Medexus Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Medexus price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Medexus using various technical indicators. When you analyze Medexus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Medexus Pharmaceuticals Predictive Indicators
The successful prediction of Medexus Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Medexus Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Medexus Pharmaceuticals based on analysis of Medexus Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Medexus Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Medexus Pharmaceuticals's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 6.91 | 9.03 | 8.13 | 8.53 | Days Of Inventory On Hand | 209.78 | 248.91 | 286.25 | 331.33 |
Pair Trading with Medexus Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medexus Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medexus Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving together with Medexus Stock
Moving against Medexus Stock
The ability to find closely correlated positions to Medexus Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medexus Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medexus Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medexus Pharmaceuticals to buy it.
The correlation of Medexus Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medexus Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medexus Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medexus Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Medexus Stock
Medexus Pharmaceuticals financial ratios help investors to determine whether Medexus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medexus with respect to the benefits of owning Medexus Pharmaceuticals security.